Applications of Alchemite™ to Drug Discovery
Introducing the Alchemite™ deep learning method for sparse experimental data.
Click below to watch the full webinar.
Event Speaker: Dr Tom Whitehead, Head of Machine Learning, Intellegens
Guest Speaker: Dr Matthew Segall, CEO, Optibrium
Through a series of real-world case studies, we explain how Alchemite™ is able to extract more information from sparse drug discovery data than competing methods, and how Intellegens and Optibrium have been collaborating to apply Alchemite™ to in-house data from global pharma companies.
Original broadcast: 2nd June 2020